Annual Operating Profit
-$167.62 M
-$7.97 M-4.99%
December 31, 2023
Summary
- As of February 26, 2025, BTAI annual operating income is -$167.62 million, with the most recent change of -$7.97 million (-4.99%) on December 31, 2023.
- During the last 3 years, BTAI annual operating profit has fallen by -$85.32 million (-103.68%).
- BTAI annual operating profit is now -7806.56% below its all-time high of -$2.12 million, reached on December 31, 2016.
Performance
BTAI Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$13.74 M
+$2.70 M+16.42%
September 30, 2024
Summary
- As of February 26, 2025, BTAI quarterly operating income is -$13.74 million, with the most recent change of +$2.70 million (+16.42%) on September 30, 2024.
- Over the past year, BTAI quarterly operating profit has stayed the same.
- BTAI quarterly operating profit is now -2497.35% below its all-time high of -$529.00 thousand, reached on March 31, 2017.
Performance
BTAI Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$74.22 M
+$30.39 M+29.05%
September 30, 2024
Summary
- As of February 26, 2025, BTAI TTM operating income is -$74.22 million, with the most recent change of +$30.39 million (+29.05%) on September 30, 2024.
- Over the past year, BTAI TTM operating profit has stayed the same.
- BTAI TTM operating profit is now -13929.87% below its all-time high of -$529.00 thousand, reached on March 31, 2017.
Performance
BTAI TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
BTAI Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.0% | 0.0% | 0.0% |
| 3 y3 years | -103.7% | 0.0% | 0.0% |
| 5 y5 years | -739.7% | 0.0% | 0.0% |
BTAI Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -56.8% | at low | at high | +74.0% | at high | +63.0% |
| 5 y | 5-year | -398.9% | at low | -63.3% | +74.0% | -120.9% | +63.0% |
| alltime | all time | -7806.6% | at low | -2497.3% | +74.0% | <-9999.0% | +63.0% |
BioXcel Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$13.74 M(-16.4%) | -$74.22 M(-29.1%) |
| Jun 2024 | - | -$16.44 M(-32.0%) | -$104.61 M(-25.6%) |
| Mar 2024 | - | -$24.16 M(+21.6%) | -$140.59 M(-16.1%) |
| Dec 2023 | -$167.62 M(+5.0%) | -$19.88 M(-55.0%) | -$167.62 M(-16.5%) |
| Sep 2023 | - | -$44.13 M(-15.8%) | -$200.64 M(+2.6%) |
| Jun 2023 | - | -$52.41 M(+2.4%) | -$195.50 M(+9.0%) |
| Mar 2023 | - | -$51.20 M(-3.2%) | -$179.37 M(+12.4%) |
| Dec 2022 | -$159.65 M(+49.3%) | -$52.89 M(+35.7%) | -$159.65 M(+20.1%) |
| Sep 2022 | - | -$38.99 M(+7.4%) | -$132.89 M(+10.1%) |
| Jun 2022 | - | -$36.29 M(+15.3%) | -$120.71 M(+7.7%) |
| Mar 2022 | - | -$31.48 M(+20.5%) | -$112.04 M(+4.8%) |
| Dec 2021 | -$106.94 M(+29.9%) | -$26.13 M(-2.5%) | -$106.94 M(+4.9%) |
| Sep 2021 | - | -$26.81 M(-2.9%) | -$101.90 M(+2.0%) |
| Jun 2021 | - | -$27.61 M(+4.7%) | -$99.86 M(+6.6%) |
| Mar 2021 | - | -$26.38 M(+25.0%) | -$93.68 M(+13.8%) |
| Dec 2020 | -$82.30 M | -$21.10 M(-14.8%) | -$82.30 M(+18.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$24.77 M(+15.5%) | -$69.61 M(+29.0%) |
| Jun 2020 | - | -$21.43 M(+42.9%) | -$53.98 M(+31.1%) |
| Mar 2020 | - | -$15.00 M(+78.2%) | -$41.18 M(+22.5%) |
| Dec 2019 | -$33.60 M(+68.3%) | -$8.41 M(-7.9%) | -$33.60 M(+3.4%) |
| Sep 2019 | - | -$9.13 M(+5.8%) | -$32.50 M(+14.1%) |
| Jun 2019 | - | -$8.63 M(+16.4%) | -$28.49 M(+23.3%) |
| Mar 2019 | - | -$7.42 M(+1.4%) | -$23.09 M(+15.7%) |
| Dec 2018 | -$19.96 M(+340.0%) | -$7.31 M(+42.9%) | -$19.96 M(+31.5%) |
| Sep 2018 | - | -$5.12 M(+57.8%) | -$15.18 M(+38.3%) |
| Jun 2018 | - | -$3.24 M(-24.3%) | -$10.97 M(+32.3%) |
| Mar 2018 | - | -$4.29 M(+69.7%) | -$8.29 M(+82.8%) |
| Dec 2017 | -$4.54 M(+114.0%) | -$2.53 M(+175.5%) | -$4.54 M(+125.6%) |
| Sep 2017 | - | -$917.00 K(+62.3%) | -$2.01 M(+83.8%) |
| Jun 2017 | - | -$565.00 K(+6.8%) | -$1.09 M(+106.8%) |
| Mar 2017 | - | -$529.00 K | -$529.00 K |
| Dec 2016 | -$2.12 M | - | - |
FAQ
- What is BioXcel Therapeutics annual operating income?
- What is the all time high annual operating profit for BioXcel Therapeutics?
- What is BioXcel Therapeutics annual operating profit year-on-year change?
- What is BioXcel Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for BioXcel Therapeutics?
- What is BioXcel Therapeutics quarterly operating profit year-on-year change?
- What is BioXcel Therapeutics TTM operating income?
- What is the all time high TTM operating profit for BioXcel Therapeutics?
- What is BioXcel Therapeutics TTM operating profit year-on-year change?
What is BioXcel Therapeutics annual operating income?
The current annual operating profit of BTAI is -$167.62 M
What is the all time high annual operating profit for BioXcel Therapeutics?
BioXcel Therapeutics all-time high annual operating income is -$2.12 M
What is BioXcel Therapeutics annual operating profit year-on-year change?
Over the past year, BTAI annual operating income has changed by -$7.97 M (-4.99%)
What is BioXcel Therapeutics quarterly operating income?
The current quarterly operating profit of BTAI is -$13.74 M
What is the all time high quarterly operating profit for BioXcel Therapeutics?
BioXcel Therapeutics all-time high quarterly operating income is -$529.00 K
What is BioXcel Therapeutics quarterly operating profit year-on-year change?
Over the past year, BTAI quarterly operating income has changed by $0.00 (0.00%)
What is BioXcel Therapeutics TTM operating income?
The current TTM operating profit of BTAI is -$74.22 M
What is the all time high TTM operating profit for BioXcel Therapeutics?
BioXcel Therapeutics all-time high TTM operating income is -$529.00 K
What is BioXcel Therapeutics TTM operating profit year-on-year change?
Over the past year, BTAI TTM operating income has changed by $0.00 (0.00%)